These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38143936)

  • 1. AIT in pediatric allergology: Opportunities and difficulties on the home stretch of the Therapy Allergen Ordinance.
    Vogelberg C; Gerstlauer M
    Allergol Select; 2023; 7():236-241. PubMed ID: 38143936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric investigation plans for specific immunotherapy: Questionable contributions to childhood health.
    Rose K; Kopp MV
    Pediatr Allergy Immunol; 2015 Dec; 26(8):695-701. PubMed ID: 26495999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunotherapy of allergies: current status].
    Mahler V; Kleine-Tebbe J; Vieths S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Nov; 63(11):1341-1356. PubMed ID: 33140209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergen Immunotherapy (AIT) in children: a vulnerable population with its own rights and legislation - summary of EMA-initiated multi-stakeholder meeting on Allergen Immunotherapy (AIT) for children, held at Paul-Ehrlich-Institut, Langen, Germany, 16.1.2019.
    Mahler V; Mentzer D; Bonertz A; Muraro A; Eigenmann P; Bousquet J; Halken S; Pfaar O; Jutel M; Wahn U; Vieths S; Kaul S
    Clin Transl Allergy; 2020; 10():28. PubMed ID: 32612805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma.
    Hesse L; Petersen AH; Nawijn MC
    Methods Mol Biol; 2021; 2223():295-335. PubMed ID: 33226602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines.
    Larenas-Linnemann D; Rodríguez-Pérez N; Luna-Pech JA; Rodríguez-González M; Blandón-Vijil MV; Del-Río-Navarro BE; Costa-Domínguez MDC; Navarrete-Rodríguez EM; Macouzet-Sánchez C; Ortega-Martell JA; Pozo-Beltrán CF; Estrada-Cardona A; Arias-Cruz A; Rodríguez Galván KG; Brito-Díaz H; Canseco-Raymundo MDR; Castelán-Chávez EE; Escalante-Domínguez AJ; Gálvez-Romero JL; Gómez-Vera J; González-Díaz SN; Guerrero-Núñez MGB; Hernández-Colín DD; Macías-Weinmann A; Mendoza-Hernández DA; Meneses-Sánchez NA; Mogica-Martínez MD; Moncayo-Coello CV; Montiel-Herrera JM; O'Farril-Romanillos PM; Onuma-Takane E; Ortega-Cisneros M; Rangel-Garza L; Stone-Aguilar H; Torres-Lozano C; Venegas-Montoya E; Wakida-Kusunoki G; Partida-Gaytán A; López-García AI; Macías-Robles AP; Ambriz-Moreno MJ; Azamar-Jácome AA; Beltrán-De Paz CY; Caballero-López C; Fernández de Córdova-Aguirre JC; Fernández-Soto JR; Lozano-Sáenz JS; Oyoqui-Flores JJ; Osorio-Escamilla RE; Ramírez-Jiménez F; Rivero-Yeverino D; Martínez Infante E; Medina-Ávalos MA
    World Allergy Organ J; 2020 Aug; 13(8):100444. PubMed ID: 32884611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world evidence for the long-term effect of allergen immunotherapy: Current status on database-derived European studies.
    Vogelberg C; Klimek L; Brüggenjürgen B; Jutel M
    Allergy; 2022 Dec; 77(12):3584-3592. PubMed ID: 36074052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergen immunotherapy and asthma: efficacy, safety, and other considerations.
    Cox L
    Allergy Asthma Proc; 2008; 29(6):580-9. PubMed ID: 19173785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma.
    Hesse L; Nawijn MC
    Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergen-specific immunotherapy in pediatric allergic asthma.
    Yukselen A
    Asia Pac Allergy; 2016 Jul; 6(3):139-48. PubMed ID: 27489785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dogmas, challenges, and promises in phase III allergen immunotherapy studies.
    De Kam PJ; Kramer MF; Shamji MH; Oluwayi K; Heath MD; Jensen-Jarolim E; Berger MH; Berger UE; Graessel A; Sellwood F; Zielen S; Vogelberg C; Zieglmayer P; Mösges R; Klimek L; DuBuske LM; Shreffler WG; Bernstein JA; Kündig TM; Skinner MA
    World Allergy Organ J; 2021 Sep; 14(9):100578. PubMed ID: 34659627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sublingual immunotherapy for allergic rhinitis.
    Wilson DR; Torres LI; Durham SR
    Cochrane Database Syst Rev; 2003; (2):CD002893. PubMed ID: 12804442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergen immunotherapy phase II trials: Challenges in dose finding.
    Kleine-Tebbe J; Kaul S; Mösges R
    Allergol Select; 2019; 3(1):1-8. PubMed ID: 32176223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergen-specific Immunotherapy for Inhalant Allergens in Children.
    Caffarelli C; Cangemi J; Mastrorilli C; Giannetti A; Ricci G
    Curr Pediatr Rev; 2020; 16(2):129-139. PubMed ID: 31642784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DGAKI and PEI in dialogue 2023: Diagnostics and allergen immunotherapy.
    Pfaar O; Hamelmann E; Taube C; Wagenmann M; Wedi B; Werfel T; Bartel D; Bonertz A; Hartenstein D; Kaul S; Mahler V; Worm M
    Allergol Select; 2023; 7():229-235. PubMed ID: 38143938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Allergen immunotherapy - a position paper of the German society for allergology and clinical immunology].
    Kleine-Tebbe J; Fuchs T; Klimek L; Kühr J; Lepp U; Niggemann B; Rakoski J; Renz H; Saloga J; Simon J
    Pneumologie; 2001 Sep; 55(9):438-44. PubMed ID: 11536068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials in allergen immunotherapy in the age group of children and adolescents: current concepts and future needs.
    Pfaar O; Gerth van Wijk R; Klimek L; Bousquet J; Creticos PS
    Clin Transl Allergy; 2020; 10():11. PubMed ID: 32346471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma.
    Vogelberg C; Brüggenjürgen B; Richter H; Jutel M
    Patient Prefer Adherence; 2020; 14():817-827. PubMed ID: 32494127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis.
    Wilson DR; Lima MT; Durham SR
    Allergy; 2005 Jan; 60(1):4-12. PubMed ID: 15575924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergen Immunotherapy in Asthma.
    Nakagome K; Nagata M
    Pathogens; 2021 Oct; 10(11):. PubMed ID: 34832562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.